
Breaking News: Cassava Sciences Successfully Resolves SEC Investigation – A Victory for Investors and the Future of Alzheimer’s Treatment!
Embracing Transparency and Accountability in the Biotechnology Industry A Closer Look at Cassava Sciences, Inc.’s Recent Settlement with the SEC In a groundbreaking move towards transparency and accountability in the biotechnology industry, Cassava Sciences, Inc. has reached a settlement with the U.S. Securities and Exchange Commission (SEC) regarding negligence-based disclosure charges. The settlement resolves a…